PD-L1 treatment slowed tumor progression in MT mice from detection to endpoint, by 10 days compared to IgG treated mice (Fig. 6B), from a median time of 46 to 56 days (p = 0.0036 HR = 3.8). The gene discussed is CD274; the disease is neoplasm.